` Comparison: NCYT vs VRTX - Alpha Spread

NCYT
vs
VRTX

Over the past 12 months, NCYT has underperformed VRTX, delivering a return of -34% compared to the VRTX's +3% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
NCYT
VRTX
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

NCYT Intrinsic Value
66.06 GBX
Undervaluation 50%
Intrinsic Value
Price
VRTX Intrinsic Value
381.81 USD
Overvaluation 24%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
Novacyt SA
LSE:NCYT
33.2 GBX
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
502.47 USD
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
NCYT, VRTX

NCYT
VRTX
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Novacyt SA
Revenue
Vertex Pharmaceuticals Inc
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
NCYT, VRTX

NCYT
VRTX
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Novacyt SA
LSE:NCYT
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

NCYT
63.4%
VRTX
86.2%

Operating Margin

NCYT
-71.7%
VRTX
39%

Net Margin

NCYT
-159.2%
VRTX
32.9%

FCF Margin

NCYT
-40.7%
VRTX
26.6%

ROE

NCYT
-54.7%
VRTX
22.5%

ROA

NCYT
-37.5%
VRTX
16.4%

ROIC

NCYT
-29.1%
VRTX
26.9%

ROCE

NCYT
-19.3%
VRTX
23%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
NCYT, VRTX

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
NCYT, VRTX

Loading
NCYT
VRTX
Difference
www.alphaspread.com

Performance By Year
NCYT, VRTX

Loading
NCYT
VRTX
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare NCYT to other stocks
PNEXF
Pharnext SCA
More expensive
vs NCYT
ABBV
Abbvie Inc
More expensive
vs NCYT
AMGN
Amgen Inc
More expensive
vs NCYT
GILD
Gilead Sciences Inc
More expensive
vs NCYT
Unlock Full Access to Alpha Spread
Create Free Account
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett